Shandong Wohua Pharmaceutical Co Ltd (002107) — Net Asset Quality Index
Shandong Wohua Pharmaceutical Co Ltd (002107) has a Net Asset Quality Index of 73.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥977.37 Million minus total liabilities of CN¥256.47 Million yields net assets of CN¥720.90 Million. A higher index indicates a stronger, lower-leverage balance sheet. Also explore Shandong Wohua Pharmaceutical Co Ltd total assets for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
Shandong Wohua Pharmaceutical Co Ltd Net Asset Quality Index Over Time (2003–2025)
This chart shows how Shandong Wohua Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 23 annual periods from 2003 to 2025. As of December 2025, the index stands at 73.8%, representing net assets of CN¥720.90 Million against total assets of CN¥977.37 Million CNY. See 002107 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Shandong Wohua Pharmaceutical Co Ltd (2003–2025)
The table below presents the year-by-year Net Asset Quality Index for Shandong Wohua Pharmaceutical Co Ltd from 2003 to 2025, covering 23 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 002107 market cap overview.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 73.8% | CN¥720.90 Million | CN¥977.37 Million | CN¥256.47 Million | ▲ +0.4 pp |
| 2024 | 73.3% | CN¥722.93 Million | CN¥985.73 Million | CN¥262.80 Million | ▲ +0.5 pp |
| 2023 | 72.8% | CN¥833.48 Million | CN¥1.14 Billion | CN¥311.23 Million | ▲ +1.0 pp |
| 2022 | 71.8% | CN¥789.79 Million | CN¥1.10 Billion | CN¥310.20 Million | ▼ -8.2 pp |
| 2021 | 80.0% | CN¥929.26 Million | CN¥1.16 Billion | CN¥231.83 Million | ▲ +13.0 pp |
| 2020 | 67.0% | CN¥918.01 Million | CN¥1.37 Billion | CN¥452.08 Million | ▼ -9.9 pp |
| 2019 | 76.9% | CN¥775.15 Million | CN¥1.01 Billion | CN¥232.87 Million | ▲ +1.5 pp |
| 2018 | 75.4% | CN¥695.78 Million | CN¥922.38 Million | CN¥226.60 Million | ▼ -1.2 pp |
| 2017 | 76.7% | CN¥655.78 Million | CN¥855.50 Million | CN¥199.71 Million | ▼ -4.5 pp |
| 2016 | 81.2% | CN¥572.64 Million | CN¥705.63 Million | CN¥132.99 Million | ▼ -0.7 pp |
| 2015 | 81.9% | CN¥547.26 Million | CN¥668.23 Million | CN¥120.97 Million | ▼ -12.6 pp |
| 2014 | 94.5% | CN¥631.74 Million | CN¥668.64 Million | CN¥36.89 Million | ▲ +0.7 pp |
| 2013 | 93.8% | CN¥605.04 Million | CN¥645.05 Million | CN¥40.01 Million | ▲ +1.5 pp |
| 2012 | 92.3% | CN¥594.41 Million | CN¥643.70 Million | CN¥49.28 Million | ▼ -1.8 pp |
| 2011 | 94.2% | CN¥586.07 Million | CN¥622.35 Million | CN¥36.28 Million | ▲ +1.3 pp |
| 2010 | 92.8% | CN¥590.64 Million | CN¥636.14 Million | CN¥45.49 Million | ▲ +3.9 pp |
| 2009 | 89.0% | CN¥688.45 Million | CN¥773.86 Million | CN¥85.41 Million | ▼ -0.6 pp |
| 2008 | 89.6% | CN¥637.88 Million | CN¥712.11 Million | CN¥74.23 Million | ▲ +14.0 pp |
| 2007 | 75.6% | CN¥342.22 Million | CN¥452.54 Million | CN¥110.32 Million | ▲ +15.5 pp |
| 2006 | 60.2% | CN¥142.57 Million | CN¥237.01 Million | CN¥94.44 Million | ▲ +3.2 pp |
| 2005 | 57.0% | CN¥111.06 Million | CN¥194.94 Million | CN¥83.88 Million | ▲ +2.9 pp |
| 2004 | 54.0% | CN¥82.62 Million | CN¥152.92 Million | CN¥70.30 Million | ▲ +15.7 pp |
| 2003 | 38.3% | CN¥51.69 Million | CN¥134.97 Million | CN¥83.28 Million | — |